BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10620725)

  • 1. Effects of absorption enhancers in chloroquine suppository formulations: I. In vitro release characteristics.
    Onyeji CO; Adebayo AS; Babalola CP
    Eur J Pharm Sci; 1999 Dec; 9(2):131-6. PubMed ID: 10620725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of various surfactants on the release of salbutamol from suppositories.
    Hanaee J; Javadzadeh Y; Taftachi S; Farid D; Nokhodchi A
    Farmaco; 2004 Nov; 59(11):903-6. PubMed ID: 15544795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation effects on the mechanical and release properties of metronidazole suppositories.
    Adegboye TA; Itiola OA
    Afr J Med Med Sci; 2003 Sep; 32(3):247-51. PubMed ID: 15030082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative hypoglycemic effect of insulin suppositories in diabetic beagle dogs: optimization of various concentrations of sodium salicylate and polyoxyethylene-9-lauryl ether.
    Hosny EA; Al-Shora HI; Elmazar MM
    Biol Pharm Bull; 2001 Nov; 24(11):1294-7. PubMed ID: 11725967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of adjuvants for enhancement of rectal absorption of cefoxitin in humans.
    Davis SS; Burnham WR; Wilson P; O'Brien J
    Antimicrob Agents Chemother; 1985 Aug; 28(2):211-5. PubMed ID: 3834830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability of oxyphenbutazone from different suppository formulations.
    Ibrahim SA; Abd Elbary A; Elsorady H; Abd Elmonem H
    Pharmazie; 1980; 35(4):213-6. PubMed ID: 7403242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of surfactant incorporation techniques on sulphamethoxazole suppository formulations.
    Abd el-Gawad AH; el-Din EZ; Abd el-Alim HA
    Pharmazie; 1988 Sep; 43(9):624-7. PubMed ID: 3244731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine absorption in children from polyethylene glycol base suppositories.
    Okor RS; Nwankwo MU
    J Clin Pharm Ther; 1988 Jun; 13(3):219-23. PubMed ID: 3209629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of immediate release diclofenac sodium suppositories.
    Sultan T; Hamid S; Hassan S; Hussain K; Ahmed A; Bashir L; Naz S; Maqbool T
    Pak J Pharm Sci; 2018 Sep; 31(5):1791-1795. PubMed ID: 30150172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of the rectal bioavailability of latamoxef sodium by adjuvants following administration of a suppository.
    Nakanishi K; Masukawa T; Masada M; Nadai T
    Biol Pharm Bull; 1994 Nov; 17(11):1496-500. PubMed ID: 7703971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mucin as a release enhancer for rectal delivery of glibenclamide.
    Adikwu MU; Okafor JO
    Curr Drug Deliv; 2006 Jul; 3(3):243-54. PubMed ID: 16848726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and In vitro Evaluation of Naproxen Suppositories.
    Hargoli S; Farid J; Azarmi SH; Ghanbarzadeh S; Zakeri-Milani P
    Indian J Pharm Sci; 2013 Mar; 75(2):143-8. PubMed ID: 24019561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel sample preparation method for surfactant containing suppositories: effect of micelle formation on drug recovery.
    Kalmár É; Ueno K; Forgó P; Szakonyi G; Dombi G
    J Pharm Biomed Anal; 2013 Sep; 83():149-56. PubMed ID: 23727364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption and distribution of radioactivity from suppositories containing 3H-benzocaine in rats.
    Ayres JW; Lorskulsint D; Lock A; Kuhl L; Laskar PA
    J Pharm Sci; 1976 Jun; 65(6):832-8. PubMed ID: 932967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the surfactant on the availability of piroxicam as a poorly hydrosoluble drug from suppositories.
    Dal Zorro M; Franceschinis E; Punchina A; Realdon N
    Pharmazie; 2012 Jan; 67(1):37-45. PubMed ID: 22393829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of availability of allopurinol from pharmaceutical dosage forms I - suppositories.
    Samy EM; Hassan MA; Tous SS; Rhodes CT
    Eur J Pharm Biopharm; 2000 Mar; 49(2):119-27. PubMed ID: 10704894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement by adjuvants on the rectal bioavailability of non-absorbable drugs following administration of suppository.
    Nakanishi K; Masada M; Nadai T
    J Pharmacobiodyn; 1990 Dec; 13(12):760-5. PubMed ID: 2098548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal absorption enhancement of gentamicin in rabbits from hollow type suppositories by sodium salicylate or sodium caprylate.
    Matsumoto Y; Watanabe Y; Tojima T; Murakoshi R; Murakami C; Matsumoto M
    Drug Des Deliv; 1989 May; 4(3):247-56. PubMed ID: 2490276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement.
    Yun M; Choi H; Jung J; Kim C
    Int J Pharm; 1999 Nov; 189(2):137-45. PubMed ID: 10536242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine.
    Miyake M; Kamada N; Oka Y; Mukai T; Minami T; Toguchi H; Odomi M; Ogawara K; Higaki K; Kimura T
    J Control Release; 2004 Sep; 99(1):63-71. PubMed ID: 15342181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.